TM
Thermo Fisher Scientific CDR (CAD Hedged) (TMO)
TSX
23.44
+0.07 (+0.30%)
Closed
Oct 7, 2026
Day's Range
23.4423.85
52 wk Range
15.7424.61
Financial Statements - TMO - Thermo Fisher Scientific CDR (CAD Hedged)
Revenue
44.55B▼ 23.6%
Net Income
6.72B▼ 22.1%Net Margin 15.1%
EBITDA
11.85B▼ 26.8%
Free Cash Flow
6.29B▼ 36.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 44.55B | 58.35B |
| Cost of Goods | 26.31B | 34.26B |
| Gross Profit | 18.23B | 24.09B |
 Operating Expense | - | - |
| Operating Income | 8.11B | 10.50B |
| Non-Operating Interest | - | - |
| Other Income Expense | -374M | -499.46M |
| Pre Tax Income | 7.30B | 9.57B |
| Income Tax | 547M | 894.14M |
| Net Income | 6.72B | 8.62B |
| EPS Basic | 0.483958 | 0.451549 |
| EPS Diluted | 0.483141 | 0.450187 |
| Basic Shares Outstanding | 13.84B | 19.08B |
| Diluted Shares Outstanding | 13.84B | 19.08B |
| Ebit | 8.72B | 11.46B |
| Ebitda | 11.85B | 16.18B |
| Net Income Continuous Operations | 6.72B | 8.62B |
| Minority Interests | -17M | -3M |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
